Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
01/2008
01/16/2008EP1877099A2 Peg and polysialic lysosomal enzyme conjugates via acid labile linkers for therapeutic targeting
01/16/2008EP1877098A2 Alpha aminoacid ester-drug conjugates hydrolysable by carboxylesterase
01/16/2008EP1877097A2 Aminoacid conjugates of beta-lapachone for tumor targeting
01/16/2008EP1877096A1 Non-lithotripsic kidney-stone therapy
01/16/2008EP1877095A1 The use of free radical scavengers for protecting and treating skin and hair damages caused by chemotherapy
01/16/2008EP1877094A1 Edible film for transmucosal delivery of nutritional supplements
01/16/2008EP1877074A2 Methods of treating and preventing inflammatory bowel disease involving il-13 and nkt cells
01/16/2008EP1877071A1 Method of improving immune function in mammals using 3-hpa producing lactobacillus strains in combination with medium chain triglyceride oil
01/16/2008EP1877066A1 Use of azithromycin for the production of a medicament for treatment of ocular infections
01/16/2008EP1877038A2 Cell-surface decoration with active agents
01/16/2008EP1789019B1 Powders containing novel oligosaccharide mixtures and methods for producing the same
01/16/2008EP1673063B1 Transdermal pharmaceutical composition
01/16/2008EP1613644A4 Peg-physiologically active polypeptide homodimer complex having prolonged in vivo half-life and process for the preparation thereof
01/16/2008EP1542904B1 Process for producing metered dose inhaler formulations
01/16/2008EP1435929B1 Composition comprising cysteamine for improving lactation in dairy animals
01/16/2008EP1326894B1 Novel tumor-associated marker
01/16/2008EP1322656B1 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
01/16/2008EP1019073B1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders
01/16/2008EP0738141B1 Sucrose ester and n-docosanol formulations
01/16/2008CN201006018Y Montmorillonite colon positioning releasing tablet
01/16/2008CN201006014Y Montmorillonite colon positioning releasing capsule
01/16/2008CN101107510A Method of measuring coating amount and method of estimating elution behavior
01/16/2008CN101107270A Method of cross-linking hyaluronic acid with divinylsulfone
01/16/2008CN101107267A Cytotoxicity mediation of cells evidencing surface expression of MCSP
01/16/2008CN101107015A Injection for mastitis
01/16/2008CN101107014A Stabilisation of glucocorticoid esters with acids
01/16/2008CN101107013A Bioactive compositions
01/16/2008CN101107012A Methods for improving liver clearance of xenobiotic substances in an animal
01/16/2008CN101106979A Therapeutic peptide formulations for coating microneedles with improved stability containing at least one counterion
01/16/2008CN101106977A Direct compression formulation and process
01/16/2008CN101106969A O/W emulsion composition
01/16/2008CN101104651A Preparation for modified chitosan metal complexes micro-sphere used for carrying medicament and preparation for the modified chitosan
01/16/2008CN101104078A Polypeptide and protein medicine polyethylene coupling compound
01/16/2008CN101104077A Recombinant human interleukin-2 and polyethylene coupling compound
01/16/2008CN101104076A Compound fructose aseptic powder for injection and its clinical application
01/16/2008CN101104043A Traditional Chinese medicine dispersion tablet for treating coronary heart disease and angina pectoris and preparing process thereof
01/16/2008CN101104027A Cough-relieving traditional Chinese medicine micropill preparation and preparation method thereof
01/16/2008CN101104015A Olive soft capsule raw material formulation and its preparation technology
01/16/2008CN101103990A Composition containing sulfonylureas sugar-reducing drug and statins lipid-lowering drug
01/16/2008CN101103984A Pharmaceutical compositions
01/16/2008CN101103982A Palonosetron hydrochloride intravenous injection medicinal composition and preparation method thereof
01/16/2008CN101103981A Medicinal composition containing tacrolimus
01/16/2008CN101103980A Fexofenadine medicinal composition
01/16/2008CN101103979A Azelnidipine medicinal composition and its preparing method
01/16/2008CN101103978A Berberine resin composition and its preparation method and medicinal composition containing the same
01/16/2008CN101103976A Oral medicinal composition containing anastrozole and preparation technology thereof
01/16/2008CN101103975A Phenytoin sodium powder injection and preparation method thereof
01/16/2008CN101103972A Oxaliplatinum liposome glucose preparation and its preparation method and application
01/16/2008CN101103968A Ambroxol oral liquid with good taste
01/16/2008CN101103967A Medicine composition containing bevantolol hydrochloride
01/16/2008CN101103965A Stable solid preparation containing amorphous cefditoren pivoxil and preparation method thereof
01/16/2008CN101103964A Sustained-release preparation containing felodipine and preparation method thereof
01/16/2008CN101103963A Levalbuterol hydrochloride orally disintegrating tablet and preparation method thereof
01/16/2008CN101103960A Dry mixed suspension containing racecadotril and preparation method thereof
01/16/2008CN100362019C Recombinant erythropoietin with intracorporeal physical activity and modified by macrogol
01/16/2008CN100361985C Paclitaxol predrug of biodegradable polymer and its synthesis method
01/16/2008CN100361709C Saccharide combination possessing protective function for life active compound
01/16/2008CN100361664C Pharmaceutical formulations
01/16/2008CN100361661C Stable eye lotion containing latanoprost as active ingredient
01/16/2008CN100361655C (-)-epigallocatechin gallate-calcium complex solid dispersion and its prepn and application
01/16/2008CN100361652C Gel type dexketoprofen plaster and method for preparing the same
01/16/2008CN100361651C Intravenous nanoparticles for targenting drug delivery and sustained drug release
01/15/2008US7319139 TAG-72 specific CH2 domain deleted antibodies
01/15/2008US7319117 Mixture containing surfactant and polymer
01/15/2008US7319094 Increased and sustained in vivo gene expression using a nucleic acid, histone and amphipathic compound composition
01/15/2008US7319033 Transcritpional control; prostate glands; anticancer agents
01/15/2008US7319004 Materials and methods relating to polyions and substance delivery
01/15/2008US7318937 Liquid coating compositions
01/15/2008US7318936 Minimization of drug oxidation in drug irradiated excipients formulations
01/15/2008US7318931 A protein, e.g., insulin or a growth hormone; a polyol, e.g., mannitol or polyethylene glycol; and a metal, e.g., zinc; stabilized against denaturing when in contact with an organic solvent.
01/15/2008US7318924 Antibodies against cancer
01/15/2008US7318918 Interferon-alpha polypeptides and conjugates
01/15/2008US7318840 Intervertebral disc treatment devices and methods
01/15/2008CA2432225C Sustained release drug delivery devices with prefabricated permeable plugs
01/15/2008CA2400567C Tamper-resistant oral opioid agonist formulations
01/15/2008CA2339166C Dextran-maleic acid monoesters and hydrogels based thereon
01/15/2008CA2332559C High molecular weight medicine-containing preparation in powder form for administration through mucosa
01/15/2008CA2312839C Compositions for nasal administration
01/15/2008CA2307776C Capsular preparation containing unsaturated fatty acid or derivative thereof and process for producing the same
01/15/2008CA2279522C Biocompatible compounds for pharmaceutical drug delivery systems
01/15/2008CA2251966C Transdermally administered dextromethorphan as antitussive agent
01/15/2008CA2251087C Injection formulations of avermectins and milbemycins based on castor oil
01/15/2008CA2250880C Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof
01/15/2008CA2244389C Cilansetron pharmaceutical preparation stabilized against racemization
01/15/2008CA2221496C Production scale method of forming microparticles
01/15/2008CA2169191C Neural regeneration using human bone morphogenetic proteins
01/15/2008CA2152563C Non-reducing saccharide and its production and use
01/15/2008CA2132740C Pharmaceutical composition containing cyclosporin derivative
01/10/2008WO2008005818A1 Glyceride esters for the treatment of diseases associated with reduced neuronal metabolism of glucose
01/10/2008WO2008005318A2 Chewy products and methods for making the same
01/10/2008WO2008005240A2 Ropinirole-containing pharmaceutical compositions in the form of a gel, uses thereof
01/10/2008WO2008005039A1 Solid compositions comprising tadalafil and at least one carrier
01/10/2008WO2008004978A1 Micelles for drug delivery
01/10/2008WO2008004542A1 Method of separating vesicle, process for producing medicinal preparation, and method of evaluation
01/10/2008WO2008004532A1 Substance-containing carbon nanohorn composite having polyamine plug and process for producing the same
01/10/2008WO2008003706A1 Two step miniemulsion process
01/10/2008WO2008003414A1 Aqueous pharmaceutical formulation of 4-[((4-carboxybutyl)-{2-[(4-phenethyl-benzyl)oxy]-phenethyl}amino)methyl] benzoic acid
01/10/2008WO2008003327A2 Immunotoxins for the treatment of diseases related to cmv infection
01/10/2008WO2007125501A3 Liquid compositions comprising phenylephrine and acetaminophen and their use for the treatment of respiratory illness
01/10/2008WO2007044892A3 Upar-binding molecule-drug conjugates and uses thereof